Electroporation News and Research

RSS

Potential new way to vaccinate against avian flu

Researchers at the University of Pennsylvania School of Medicine have identified a potential new way to vaccinate against avian flu. By delivering vaccine via DNA constructed to build antigens against flu, along with a minute electric pulse, researchers have immunized experimental animals against various strains of the virus.

1 Jul 2008

MaxCyte introduces large scale transfection technology - accelerates cell-based assay development

MaxCyte has announced the introduction of its ITF Inline Transfection System, a validated platform for preparative transfection, based on unique flow electroporation technology.

21 Apr 2008

Thermo Fisher Scientific creates breakthrough gene-silencing tool

Thermo Fisher Scientific Inc. has developed a breakthrough gene-silencing tool that greatly simplifies RNA- interference (RNAi) technology and eliminates barriers associated with previous cellular delivery methods.

From Thermo Fisher Scientific Inc. 12 Mar 2008

Cold Spring Harbor Protocols features innovative methods for embryology research

Two methods that permit scientists to examine critical stages in early embryogenesis are featured in this month's release of Cold Spring Harbor Protocols.

4 Dec 2007

New minimally invasive method of treating cancer

A team of biomedical engineers at Virginia Tech and the University of California at Berkeley has developed a new minimally invasive method of treating cancer, and they anticipate clinical trials on individuals with prostate cancer will begin soon.

9 Jul 2007

Vical and NIH to evaluate enhanced-delivery HIV vaccine

Vical Incorporated today announced plans to develop and evaluate electroporation-enhanced delivery of therapeutic and preventive DNA vaccines against HIV

12 Sep 2005

Ichor Medical Systems issued key patent

Ichor Medical Systems today announced that it has been issued a patent that protects vital elements of the company's technology.

25 Aug 2005

Participants in the gene therapy market discover new ways to improve clinical efficiency and generate revenue

The gene therapy market has had limited success with products during the clinical development process. Due to toxicological complications and poor therapy efficacy, healthcare authorities have suspended several gene therapy trials worldwide.

28 Jul 2005

Promising new therapy that prompts the immune system to aid in the fight against melanoma tumors

Melanoma is a particularly deadly form of skin cancer very resistant to treatment. Researchers at H. Lee Moffitt Cancer Center & Research Institute and the University of South Florida are testing a promising new therapy that prompts the immune system to aid in the fight against melanoma tumors.

5 Apr 2005

$11 million for lung injury research

Northwestern University has received an $11 million Program Project Grant (PPG) from the National Institutes of Health to define the mechanisms that cause changes in the alveolar epithelium during lung injury.

27 Apr 2004